Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pharmacology Research & Perspectives
|
June 10, 2017
Characterizing QT interval prolongation in early clinical development: a case study with methadone
Vincent F S Dubois, Meindert Danhof, Oscar Della Pasqua
British Journal of Clinical Pharmacology
|
August 8, 2014
Model-based evaluation of drug-induced QTc prolongation for compounds in early development
Vincent F S Dubois, Huixin Yu, Meindert Danhof, et al.
Pharmaceutics
|
April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total
John Hood, Ignacio González-García, Nicholas White, et al.
British Journal of Clinical Pharmacology
|
January 29, 2013
Identifying the translational gap in the evaluation of drug-induced QTc interval prolongation
Anne S Y Chain, Vincent F S Dubois, Meindert Danhof, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy
Ignacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic models
Van Thuy Truong, Paul G Baverel, Grant D Lythe, et al.
British Journal of Clinical Pharmacology
|
September 11, 2016
Translating QT interval prolongation from conscious dogs to humans
Vincent F S Dubois, Giovanni Smania, Huixin Yu, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status
Paul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Journal of the American Heart Association
|
January 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pharmacology Research & Perspectives
|
June 10, 2017
Characterizing QT interval prolongation in early clinical development: a case study with methadone
Vincent F S Dubois, Meindert Danhof, Oscar Della Pasqua
British Journal of Clinical Pharmacology
|
August 8, 2014
Model-based evaluation of drug-induced QTc prolongation for compounds in early development
Vincent F S Dubois, Huixin Yu, Meindert Danhof, et al.
Pharmaceutics
|
April 30, 2021
Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total
John Hood, Ignacio González-García, Nicholas White, et al.
British Journal of Clinical Pharmacology
|
January 29, 2013
Identifying the translational gap in the evaluation of drug-induced QTc interval prolongation
Anne S Y Chain, Vincent F S Dubois, Meindert Danhof, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 19, 2021
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy
Ignacio González-García, Vadryn Pierre, Vincent F S Dubois, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 16, 2021
Step-by-step comparison of ordinary differential equation and agent-based approaches to pharmacokinetic-pharmacodynamic models
Van Thuy Truong, Paul G Baverel, Grant D Lythe, et al.
British Journal of Clinical Pharmacology
|
September 11, 2016
Translating QT interval prolongation from conscious dogs to humans
Vincent F S Dubois, Giovanni Smania, Huixin Yu, et al.
Clinical Pharmacology and Therapeutics
|
December 16, 2017
Population Pharmacokinetics of Durvalumab in Cancer Patients and Association With Longitudinal Biomarkers of Disease Status
Paul G Baverel, Vincent F S Dubois, Chao Yu Jin, et al.
Journal of the American Heart Association
|
January 23, 2023
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
Andrea L Vavere, Marvin Sinsakul, Emily L Ongstad, et al.
Page
of 1